BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Byrd JK, Yawn RJ, Wilhoit CS, Sora ND, Meyers L, Fernandes J, Day T. Well differentiated thyroid carcinoma: current treatment. Curr Treat Options Oncol 2012;13:47-57. [PMID: 22234582 DOI: 10.1007/s11864-011-0173-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Gruber JJ, Colevas AD. Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients. Oncologist 2015;20:113-26. [PMID: 25616432 DOI: 10.1634/theoncologist.2014-0313] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
2 Cheng Q, Li X, Acharya CR, Hyslop T, Sosa JA. A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors. Oncotarget 2017;8:16690-703. [PMID: 28187428 DOI: 10.18632/oncotarget.15128] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Huang K, Luo D, Huang M, Long M, Peng X, Li H. Protection of parathyroid function using carbon nanoparticles during thyroid surgery. Otolaryngol Head Neck Surg 2013;149:845-50. [PMID: 24163324 DOI: 10.1177/0194599813509779] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
4 Werner TA, Nolten I, Dizdar L, Riemer JC, Schütte SC, Verde PE, Raba K, Schott M, Knoefel WT, Krieg A. IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancer. Endocr Relat Cancer 2018;25:295-308. [PMID: 29317481 DOI: 10.1530/ERC-17-0479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bojoga A, Koot A, Bonenkamp J, de Wilt J, IntHout J, Stalmeier P, Hermens R, Smit J, Ottevanger P, Netea-Maier R. The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis. J Clin Med 2020;9:E2316. [PMID: 32708218 DOI: 10.3390/jcm9072316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Guo L, Ma YQ, Yao Y, Wu M, Deng ZH, Zhu FW, Luo YK, Tang J. Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma. Sci Rep 2019;9:75. [PMID: 30635590 DOI: 10.1038/s41598-018-36171-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
7 Cheng X, Yao X, Xu S, Pan J, Yu H, Bao J, Guan H, Lu R, Zhang L. Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway. Biomed Pharmacother 2018;103:490-8. [PMID: 29677534 DOI: 10.1016/j.biopha.2018.04.074] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
8 Lebo NL, Raymond F, Odell MJ. Selectively false-positive radionuclide scan in a patient with sarcoidosis and papillary thyroid cancer: a case report and review of the literature. J Otolaryngol Head Neck Surg 2015;44:18. [PMID: 25971453 DOI: 10.1186/s40463-015-0069-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]